Health Literacy-Informed Digital Intervention Reduces Obesity at Age 2 Years
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 8, 2024 -- A health literacy-informed digital intervention reduces the incidence of obesity at 24 months of age, according to a study published online Nov. 3 in the Journal of the American Medical Association to coincide with the annual meeting of The Obesity Society (ObesityWeek), held from Nov. 3 to 6 in San Antonio.
William J. Heerman, M.D., M.P.H., from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues compared the effectiveness of adding a digital childhood obesity prevention intervention to health behavior counseling. Pediatric clinicians used health literacy-informed booklets at well-child visits to promote healthy behaviors in the clinic-based health behavior counseling group; families also received health literacy-informed, individually tailored, responsive text messages to support health behavior goals in the clinic + digital intervention group (451 and 449 participants, respectively).
The researchers found that the mean weight-for-length trajectory was lower for children in the clinic + digital intervention group, with an estimated reduction of 0.33 kg/m at 24 months. In addition, there was an adjusted mean difference of −0.19 for both weight-for-length z score and body mass index z score. At 24 months, 23.2 and 24.5 percent of the clinic + digital intervention group and the clinic-only group, respectively, had overweight or obesity (adjusted risk ratio, 0.91; 95 percent confidence interval, 0.70 to 1.17). At 24 months, 7.4 and 12.7 percent of the clinic + digital intervention group and the clinic-only group, respectively, had obesity (adjusted risk ratio, 0.56; 95 percent confidence interval, 0.36 to 0.88).
"The substantial reduction in risk of childhood obesity observed in this study could have significant population-level impact if implemented at scale," the authors write.
One author disclosed ties to Medeloop.ai, an artificial intelligence-driven platform that supports clinical research.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.